Risk assessment scale for pressure ulcers in pediatric patients: French translation, internal consistency, convergent validity, feasibility, and clinical utility of the Braden QD Scale
| Autor: | Verdon M; Infirmière, Ph.Dc, chargée de recherche et qualité des soins, Hôpitaux Universitaires de Genève, Genève, Suisse, Rae AC; Infirmière, chargée de recherche et qualité des soins, Hôpitaux Universitaires de Genève, Genève, Suisse, Palleron C; Infirmière, spécialiste clinique, Hôpitaux Universitaires de Genève, Genève, Suisse, Roulin MJ; Infirmière, Ph.D, adjointe de direction, Hôpitaux Universitaires de Genève, Genève, Suisse ; professeure agréée, Institut et Haute École de la Santé La Source, HES-SO, Haute École Spécialisée de Suisse Occidentale, Lausanne, Suisse |
|---|---|
| Jazyk: | francouzština |
| Zdroj: | Recherche en soins infirmiers [Rech Soins Infirm] 2022; Vol. 149 (2), pp. 51-61. |
| DOI: | 10.3917/rsi.149.0051 |
| Abstrakt: | Introduction: Pediatric patients are particularly vulnerable to pressure ulcers. Structured evaluation with a risk assessment tool is recommended in order to identify patients at risk. The Braden QD Scale integrates the risks of both immobility-related and medical device-related pressure ulcers in pediatric patients. Objectives: To translate and pretest the Braden QD Scale into French (Swiss-French version), and to evaluate its consistency, convergent validity, feasibility, and clinical utility. Method: Over five prevalence surveys, the Braden QD Scale was used on all hospitalized pediatric patients. Convergent validity and internal consistency were tested. A self-administered questionnaire on feasibility and clinical utility was completed by nurses. Results: The translated version of the Braden QD Scale was pretested on 352 children. The prevalence surveys showed that 5.1% were at risk of developing pressure ulcers. Medical devices were present in 85.8% of cases. A Cronbach's alpha of 0.710 and a high convergent validity were measured. High scores of feasibility and clinical utility were found. Discussion and Conclusion: This study suggests that the Swiss-French version of the Braden QD Scale is reliable, valid, feasible, and has clinical utility. |
| Databáze: | MEDLINE |
| Externí odkaz: |
|